OBJECTIVE: ACOG and SMFM recommend that institutions screen for severe maternal morbidity (SMM) and review cases to determine which "screen" positive cases represent true morbidity. Previous validation studies have evaluated screen positive, but not screen negative cases. This limits our understanding of the performance of the screening criteria. Our objective was to validate four common screening criteria, and apply our false-negative rate to a previous validation study. STUDY DESIGN: From an administrative delivery database of deliveries born at Magee-Womens Hospital (2010 -2011 , we selected all deliveries that screened positive for SMM (n¼349) and a random sample of screen-negative deliveries (n¼349). Screenpositives were those that had any of the following: 1 of the CDC ICD-9 Revision diagnosis and procedure codes for severe maternal morbidity; prolonged postpartum length of stay (>3 standard deviations beyond the mean length of stay by mode of delivery); maternal ICU admission; or administration of any blood product. We used the Gold Standard SMM Case Review Guidelines (ACOG/ SMFM Obstetric Care Consensus 2016) to identify true cases after medical record review. We calculated positive and negative predictive value of the screening criteria. The study was approved by our institutional review board. RESULTS: Compared with women who screened negative for severe maternal morbidity, those who screened positive were more likely to be non-White (33% vs. 17%), obese (31% vs. 16%), and to have a preterm birth (38% vs. 6.9%) or small-for-gestational-age infant (17% vs. 7.5%). A total of 166 screen positive cases were true positives (48% positive predictive value), and 347 screen negative cases were true negatives (99% negative predictive value). Notably, 2 screen negative cases were false negatives-one due to a coding error and another due to a postpartum readmission for pulmonary embolism that was not in the delivery database. If this false negative rate were applied to the largest SMM validation study (Main et al. AJOG 2016) of 67,468 birth, there would be nearly as many false negative (n¼379) as true positives (n¼491). CONCLUSION: The false negative cases in our study are driven by data entry error as well as limitations of delivery administrative data that do not capture the postpartum period. Understanding the false negatives is critical to institutions establishing comprehensive screen and review programs to improve obstetrical care. OBJECTIVE: Conditions of ischemic placental disease (IPD)-preeclampsia, abruption, and intrauterine growth restriction (IUGR)-more often occur together when they occur in the preterm period, suggesting a common pathophysiologic mechanism for IPD at preterm gestations. In vitro fertilization (IVF) is associated with IPD, though the mechanism is unclear. We evaluated the effect of gestational age on the association between IVF and IPD and hypothesized that IVF would be more strongly associated with preterm IPD than term IPD. STUDY DESIGN: The cohort included deliveries from 2000 to 2015 at a tertiary hospital. We used data from an affiliated infertility treatment center and birth certificates to determine if the pregnancy was due to IVF or spontaneous (non-IVF). The primary outcomes were preterm and term IPD (preeclampsia, placental abruption, small-forgestational age infant (SGA), or an intrauterine fetal demise (IUFD) due to placental insufficiency). We defined SGA as <10 th percentile using U.S. growth curves and preterm as <37 weeks' gestation at delivery. We used log-binomial regression to estimate risk ratios (RR) and 95% confidence intervals (CI), adjusted for maternal age and/or parity. RESULTS: Of the 69,084 deliveries, 3,763 (5.4%) were IVF pregnancies. The incidence of preterm delivery was 32.6% in IVF pregnancies and 10.8% in non-IVF pregnancies. Compared to non-IVF pregnancies, IVF pregnancies were more likely to develop IPD/IUFD due to placental insufficiency. The effect was stronger for preterm deliveries (RR: 4.0; 95% CI: 3.7-4.4) than term deliveries (RR: 1.7; 95% CI: 1.6-1.9). IVF pregnancies had a higher risk of each component of IPD,and the risks were stronger in the preterm period (Table) . The cumulative incidence of IPD was higher for IVF pregnancies at every gestational age (Figure) . University of Illinois, Urbana-Champaign, IL OBJECTIVE: Opioid overdose related deaths account for 11-20% of pregnancy-associated deaths in the United States. Recent studies show opioid use for short-term pain indications, such as childbirth, can trigger opioid misuse. Mental health disorders, such as depression, increase the risk of an opioid misuse disorder. There is increased risk for depression during the perinatal period. Research on opioid use among postpartum women with depression is limited. The purpose of this study is to evaluate the prevalence of opioid prescriptions and depression among postpartum women, and the relationship between depression and opioid use.
